Catalyst Pharmaceuticals, Inc. (CPRX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$23.99
Day's range
$24.89

Catalyst Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 08/07/2026 19.16 M $602.16 M   2.05% 15.67%
STATE STREET CORP 08/07/2026 7.63 M $239.72 M   11.13% 6.24%
AMERICAN CENTURY COMPANIES INC 08/12/2026 5.55 M $174.56 M   34.20% 4.54%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 5.14 M $161.40 M   0.25% 4.20%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 08/24/2026 3.90 M $123.94 M   2,668.36% 3.19%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 3.63 M $114.22 M   5.96% 2.97%
GLAZER CAPITAL, LLC 08/17/2026 3.60 M $113.24 M   100.00% 2.95%
JPMORGAN CHASE & CO 08/12/2026 3.17 M $99.89 M   579.04% 2.59%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 3.15 M $99.03 M   5.98% 2.58%
HBK INVESTMENTS L P 08/14/2026 2.82 M $88.64 M   100.00% 2.31%
MORGAN STANLEY 08/13/2026 2.76 M $86.76 M   2.72% 2.26%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 2.43 M $76.34 M   -1.88% 1.99%
JUPITER TOPCO LLC 08/14/2026 2.28 M $71.60 M   100.00% 1.86%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 2.25 M $70.85 M   446.29% 1.84%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 2.14 M $67.14 M   -9.01% 1.75%
BOSTON PARTNERS 08/04/2026 1.66 M $52.15 M   -3.08% 1.36%
NEXPOINT ASSET MANAGEMENT, L.P. 08/14/2026 1.60 M $50.37 M   100.00% 1.31%
UBS GROUP AG 08/13/2026 1.45 M $45.69 M   47.42% 1.19%
NORTHERN TRUST CORP 08/13/2026 1.33 M $41.82 M   7.49% 1.09%
BANK OF AMERICA CORP /DE/ 08/14/2026 1.31 M $41.22 M   -56.81% 1.07%
GOLDMAN SACHS GROUP INC 08/14/2026 1.19 M $37.53 M   21.27% 0.98%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 1.16 M $36.44 M   -18.91% 0.95%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 1.16 M $36.44 M   100.00% 0.95%
POLAR ASSET MANAGEMENT PARTNERS INC. 08/14/2026 1.15 M $36.15 M   100.00% 0.94%
MILLENNIUM MANAGEMENT LLC 08/14/2026 1.07 M $33.59 M   39.34% 0.87%
WATER ISLAND CAPITAL LLC 08/14/2026 933.82 K $29.35 M   100.00% 0.76%
MARSHALL WACE, LLP 08/13/2026 911.70 K $28.65 M   351.75% 0.75%
KENNEDY CAPITAL MANAGEMENT LLC 08/14/2026 856.61 K $26.92 M   -28.59% 0.70%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 830.67 K $26.11 M   3.49% 0.68%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 08/13/2026 795.70 K $25.01 M   100.00% 0.65%
SWEDBANK AB 07/15/2026 775.03 K $24.36 M   25.79% 0.63%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 08/13/2026 748.92 K $23.54 M   -21.60% 0.61%
BANK OF NEW YORK MELLON CORP 08/06/2026 703.23 K $22.10 M   3.07% 0.58%
PRINCIPAL FINANCIAL GROUP INC 08/04/2026 683.27 K $21.48 M   1.08% 0.56%
AQR ARBITRAGE LLC 08/14/2026 674.22 K $21.19 M   100.00% 0.55%
SYSTEMATIC FINANCIAL MANAGEMENT LP 08/14/2026 667.88 K $20.99 M   -10.65% 0.55%
FIL LTD 08/13/2026 650.00 K $20.43 M   100.00% 0.53%
SAGEFIELD CAPITAL LP 08/14/2026 569.48 K $17.90 M   100.00% 0.47%
GLENMEDE TRUST CO NA 08/10/2026 501.21 K $15.75 M   -11.36% 0.41%
INVESCO LTD. 08/14/2026 445.99 K $14.02 M   -40.76% 0.36%
NUVEEN, LLC 08/11/2026 437.35 K $13.75 M   4.25% 0.36%
GABLES CAPITAL MANAGEMENT INC. 08/10/2026 419.18 K $13.17 M   -1.27% 0.34%
FIRST TRUST CAPITAL MANAGEMENT L.P. 08/13/2026 416.21 K $13.08 M   100.00% 0.34%
PUBLIC SECTOR PENSION INVESTMENT BOARD 08/13/2026 395.19 K $12.42 M   -24.92% 0.32%
JW ASSET MANAGEMENT, LLC 08/07/2026 388.39 K $12.21 M   0.00% 0.32%
ALLIANZ ASSET MANAGEMENT GMBH 08/14/2026 372.99 K $9.24 M   0.00% 0.31%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 08/12/2026 371.53 K $11.68 M   -22.44% 0.30%
FMR LLC 08/13/2026 360.47 K $11.33 M   30.24% 0.29%
ROYCE & ASSOCIATES LP 08/14/2026 358.64 K $11.27 M   -82.84% 0.29%
SOROS FUND MANAGEMENT LLC 08/14/2026 344.59 K $10.83 M   100.00% 0.28%

Catalyst Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 558 institutional investors and hedge funds held shares of Catalyst Pharmaceuticals Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 19.16 M

STATE STREET CORP: 7.63 M

AMERICAN CENTURY COMPANIES INC: 5.55 M

VANGUARD CAPITAL MANAGEMENT LLC: 5.14 M

DIMENSIONAL FUND ADVISORS LP: 3.63 M

GLAZER CAPITAL, LLC: 3.6 M

89.01% of Catalyst Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 144.94 M shares in the last 24 months. This purchase volume represents approximately $3.59 B in transactions.